PsiOxus Therapeutics PsiOxus - a great place to work - PsiOxus Therapeutics

Home
Contact

PsiOxus – a great place to work!

Comments are closed.

Sign up to our mailing list

Mailing list sign up

Email *

If you are human, leave this field blank.

Vision & Strategy

Vision & Strategy

We aim to lead the world in tumor re-engineering.

Technology & Products

T-SIGn Product Platform

View our T-Sign technology here.

T-SIGn Pipeline

T-SIGn Pipeline

View information on our clinical trials here.

People & Investors

Our People

PsiOxus brings together highly experienced management and investors.

Latest News & Events

PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and Metastases

14th April 2021

PsiOxus Therapeutics updates agreement with Bristol-Myers Squibb to advance their clinical stage immuno-oncology collaboration

6th April 2021

Priya Mande, PsiOxus COO, listed in the Top 25 Women Leaders in Biotechnology for 2020

10th November 2020

logo

Email
Links
Sitemap
Privacy Policy

Copyright

Designed and Produced by www.imageworks.co.uk
© Copyright 2019 PsiOxus Therapeutics

© Copyright 2021 PsiOxus Therapeutics

RSS

About
Vision & Strategy
Our People
T-SIGn Platform Technology
- Pipeline
- Publications and Posters
Partners and Investors
News and Events
Careers
Contact Us

Responsive Menu Pro Image

Responsive Menu Clicked Image

Menu